Himal Lal
Pfizer (United States)(US)
Publications by Year
Research Areas
Herpesvirus Infections and Treatments, Acne and Rosacea Treatments and Effects, Poxvirus research and outbreaks, Cytomegalovirus and herpesvirus research, Healthcare and Venom Research
Most-Cited Works
- → Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults(2015)1,378 cited
- → Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older(2016)1,017 cited
- → Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older(2018)192 cited
- → Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years(2021)158 cited
- → Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults(2015)122 cited
- → Persistence of immune response to an adjuvanted varicella-zoster virus subunit vaccine for up to year nine in older adults(2018)78 cited
- → Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older(2017)76 cited
- → Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine(2017)72 cited
- → Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials(2019)62 cited
- → Quality of Life Impact of an Adjuvanted Recombinant Zoster Vaccine in Adults Aged 50 Years and Older(2018)57 cited